INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "METHODS FOR IDENTIFYING BIOMARKERS OF TREATMENT RESPONSE AND USE THEREOF WITH A CDK4 INHIBITOR"

GENEVA, Oct. 4 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/053096) for "METHODS FOR IDENTIFYING BIOMARKERS OF TREATMENT RESPONSE AND USE THEREOF WITH A CDK4 INHIBITOR" on Mar 24, 2025. With publication no. WO/2025/202871, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDERS, Lars (c/o Pfizer Inc.10777 Science Center DriveSan Diego, California 92121), LI, Danan (11547 Westview ParkwaySan Diego, California 92126), MCMILLAN, Elizabeth Anne (1536 Olive Ave.Vi...